Thrombolysis with recombinant tissue-type plasminogen activator in renal venous thrombosis in infancy

The Lancet

Volumn 340, Issue 8827, 1992, Pages 1105-

  Nowak Gottl U ^a   Schwabe, D ^a   Schneider, W ^a   Schlosser R ^a   Kreuz, W ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; HEPARIN; STREPTOKINASE; UROKINASE;

BLOOD CLOT LYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY VEIN; LETTER; PRIORITY JOURNAL; THROMBOSIS;

HUMAN; INFANT, NEWBORN; RECOMBINANT PROTEINS; RENAL VEINS; THROMBOLYTIC THERAPY; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0026702726     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)93134-9     Document Type: Letter

References (8)

1. Acute renal failure in neonates: incidence, etiology and outcome
2. Fibrinolytic therapy for renal vein thrombosis in the child
3. Low-dose fibrinolytic therapy in infants
4. Die Prophylaxe von Reocclusion von Infarktegafäßen nach intrakoronarer Thrombolyse: Einfluß von Antithrombin III?
5. Tissue plasminogen activator for the treatment of thromboembolism in infants and children
6. Plasminogen activation by tissue activator is accelerated in the presence of fibrinogen cyanogen bromide fragment FCB-2
7. Pharmacokinetics of antigen and activity of recombinant tissue-type plasminogen activator after infusion in healthy volunteers
8. Development of the hemostatic system in the neonate and young infant